Recombinant Activated Factor VII in the Treatment of Bleeding Episodes in Patients With Inherited and Acquired Bleeding Disorders
- 1 April 1993
- journal article
- review article
- Published by Elsevier in Transfusion Medicine Reviews
- Vol. 7 (2), 78-83
- https://doi.org/10.1016/s0887-7963(93)70126-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Control of haemostasis with recombinant factor VIIa in patient with inhibitor to factor VIIIThe Lancet, 1991
- PROLONGED RECOMBINANT ACTIVATED FACTOR VII (rFVIIa) TREATMENT FOR SEVERE BLEEDING IN A FACTOR‐IX‐DEFICIENT PATIENT WITH AN INHIBITORBritish Journal of Haematology, 1991
- Use of recombinant activated factor VII for treatment of a retropharyngeal hemorrhage in a hemophilic patient with a high titer inhibitorAmerican Journal of Hematology, 1989
- Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease.Proceedings of the National Academy of Sciences, 1989
- SUCCESSFUL USE OF RECOMBINANT FACTOR VIIa IN PATIENT WITH SEVERE HAEMOPHILIA A DURING SYNOVECTOMYThe Lancet, 1988
- Characterization of a cDNA coding for human factor VII.Proceedings of the National Academy of Sciences, 1986
- Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors.Journal of Clinical Investigation, 1983
- MYOCARDIAL INFARCTION COMPLICATING ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE SUBSTITUTION IN PATIENT WITH HAEMOPHILIA AThe Lancet, 1982
- The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIIINew England Journal of Medicine, 1981
- Efficacy of Prothrombin-Complex Concentrates in Hemophiliacs with Antibodies to Factor VIIINew England Journal of Medicine, 1980